Literature DB >> 18071095

Alexithymia and emotional distress in patients with central serous chorioretinopathy.

Rupert Conrad1, Nina Friederike Weber, Matthias Lehnert, Frank Gerhard Holz, Reinhard Liedtke, Nicole Eter.   

Abstract

The authors studied 31 consecutive patients newly diagnosed with central serous chorioretinopathy (CSC) as compared with 31 age- and gender-matched control subjects, assessing emotional distress (ED), nine psychopathological symptoms, critical life events, and alexithymia. Results showed no difference in the number of critical life events; however CSC patients showed elevated ED and elevated scores on seven psychopathological symptoms, including hostility. Controlling for ED, CSC patients showed elevated alexithymia sum scores. Alexithymia was correlated with hostility. Our findings point to personality-based difficulties in emotional regulation associated with hostility in CSC.

Entities:  

Mesh:

Year:  2007        PMID: 18071095     DOI: 10.1176/appi.psy.48.6.489

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  15 in total

1.  [Central serous chorioretinopathy (CSC)].

Authors:  H Baraki; N Feltgen; J Roider; H Hoerauf; C Klatt
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

2.  [Sudden unilateral loss of vision under high-dosage corticosteroid therapy for pansinusitis].

Authors:  F Alten; C H Meyer
Journal:  HNO       Date:  2011-05       Impact factor: 1.284

3.  Angiographic characteristics of central serous chorioretinopathy in an Egyptian population.

Authors:  Maha M Shahin
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

4.  QT interval dispersion in the patients with central serous chorioretinopathy.

Authors:  Necati Dagli; Burak Turgut; Rumeysa Tanyildizi; Sabiha Kobat; Mehmet Ali Kobat; Orhan Dogdu
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

5.  A novel mutation of sgk-1 gene in central serous chorioretinopathy.

Authors:  Mahmut Akyol; Muhammet Kazım Erol; Ozdemir Ozdemir; Deniz Turgut Coban; Ahmet Burak Bilgin; Esin Sogutlu Sari; Elif Betul Turkoglu
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

6.  CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Alexandre Matet; Suzanne Yzer; Emily Y Chew; Alejandra Daruich; Francine Behar-Cohen; Richard F Spaide
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

Review 7.  [Central serous chorioretinopathy].

Authors:  Laurenz Pauleikhoff; Hansjürgen Agostini; Clemens Lange
Journal:  Ophthalmologe       Date:  2021-04-16       Impact factor: 1.059

8.  Fundus Autofluorescence and Spectral Domain OCT in Central Serous Chorioretinopathy.

Authors:  Luiz Roisman; Daniel Lavinsky; Fernanda Magalhaes; Fabio Bom Aggio; Nilva Moraes; Jose A Cardillo; Michel E Farah
Journal:  J Ophthalmol       Date:  2011-08-08       Impact factor: 1.909

9.  Temperament and character personality profile and illness-related stress in central serous chorioretinopathy.

Authors:  Rupert Conrad; Franziska Geiser; Alexandra Kleiman; Berndt Zur; Andrea Karpawitz-Godt
Journal:  ScientificWorldJournal       Date:  2014-02-16

10.  Cushing's Syndrome and Hypothalamic-Pituitary-Adrenal Axis Hyperactivity in Chronic Central Serous Chorioretinopathy.

Authors:  Femke M van Haalen; Elon H C van Dijk; Olaf M Dekkers; Maurice B Bizino; Greet Dijkman; Nienke R Biermasz; Camiel J F Boon; Alberto M Pereira
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-20       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.